10x Genomics, Inc. (NASDAQ:TXG – Free Report) – William Blair lifted their Q2 2024 EPS estimates for 10x Genomics in a note issued to investors on Wednesday, May 1st. William Blair analyst M. Larew now anticipates that the company will post earnings per share of ($0.53) for the quarter, up from their prior forecast of […]
TD Cowen cut shares of 10x Genomics (NASDAQ:TXG – Free Report) from a buy rating to a hold rating in a research note released on Wednesday morning, MarketBeat reports. The brokerage currently has $32.00 target price on the stock, down from their previous target price of $57.00. TXG has been the subject of several other […]
10x Genomics (NASDAQ:TXG – Free Report) had its price target reduced by The Goldman Sachs Group from $30.00 to $26.00 in a research report released on Wednesday, Benzinga reports. They currently have a sell rating on the stock. A number of other research firms also recently weighed in on TXG. TD Cowen downgraded shares of […]
TD Cowen lowered shares of 10x Genomics (NASDAQ:TXG – Free Report) from a buy rating to a hold rating in a research report sent to investors on Wednesday morning, Marketbeat Ratings reports. TD Cowen currently has $32.00 price target on the stock, down from their prior price target of $57.00. Several other research firms have […]
10x Genomics (NASDAQ:TXG – Free Report) had its price objective trimmed by Stifel Nicolaus from $63.00 to $53.00 in a report published on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. Other equities analysts have also recently issued research reports about the stock. Canaccord Genuity Group reduced their price target […]